Does intravenous lidocaine reduce opioid requirements after day case gynaecological laparoscopy? - Lidocaine for gynaecological laparoscopy v1.2

South Warwickshire NHS Foundation Trust0 sites60 target enrollmentApril 27, 2011

Overview

No summary available.

Registry

who.int

Start Date

April 27, 2011

End Date

TBD

Last Updated

14 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

Female

Sponsor

•Adult female patients of ASA I or II scheduled for elective day case gynaecological laparoscopic procedure (laparoscopy \+/\- diathermy)with the exception of laparoscopic tubal ligation.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range

•Inability to give informed consent Patients undergoing laparoscopy with tubal ligation Pregnancy Intolerance or allergy to non\-steroidal anti inflammatory agents (NSAIDS) Intolerance or allergy to paracetamol Intolerance or allergy to lignocaine or other amide local anaesthetic agent Renal or hepatic impairment Congestive cardiac failure, sino\-atrial disorders, atrio\-ventricular block (all grades) Patients recieving treatment with beta blocking agents Patients receiving antipsychotic agents which prolong the QT interval Patients receiving treatment with Atazanavir, Lopinavir, Darunavir, Fosamprenavir Patients suffering from hypokalaemia (K\+ \< 3\.5mmol/L) Acute porphyria Myasthenia gravis ASA status III or IV Patients prescribed pre\-operative opioid analgesic agents Active gastro\-oesphageal reflux disease, patients receiving regular cimetidine Patients scheduled for laparoscopy plus microwave endometrial ablation therapy